JPY6,596.00
0.86% today
Tokyo, Feb 05, 07:15 am CET
ISIN
JP3519400000
Symbol
4519
Index
Sector
Industry

Chugai Pharmaceutical Target price 2025 - Analyst rating & recommendation

Chugai Pharmaceutical Classifications & Recommendation:

Buy
47%
Hold
53%

Chugai Pharmaceutical Price Target

Target Price JPY7,596.15
Price JPY6,625.00
Potential
Number of Estimates 13
13 Analysts have issued a price target Chugai Pharmaceutical 2026 . The average Chugai Pharmaceutical target price is JPY7,596.15. This is higher than the current stock price. The highest price target is
JPY9,900.00 49.43%
register free of charge
, the lowest is
JPY5,300.00 20.00%
register free of charge
.
A rating was issued by 15 analysts: 7 Analysts recommend Chugai Pharmaceutical to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of . Most analysts recommend the Chugai Pharmaceutical stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion JPY 1,170.61 1,186.86
5.33% 1.39%
EBITDA Margin 48.81% 49.18%
21.24% 0.77%
Net Margin 33.09% 34.41%
12.96% 3.99%

14 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is

JPY1.2t
Unlock
. This is
1.39% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY1.3t 7.26%
Unlock
, the lowest is
JPY1.1t 4.24%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 JPY1.2t 5.33%
2025
JPY1.2t 1.39%
Unlock
2026
JPY1.2t 3.81%
Unlock
2027
JPY1.3t 5.49%
Unlock
2028
JPY1.4t 9.12%
Unlock
2029
JPY1.5t 5.15%
Unlock

7 Chugai Pharmaceutical Analysts have issued a net profit forecast 2025. The average Chugai Pharmaceutical net profit estimate is

JPY408b
Unlock
. This is
5.43% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY445b 15.01%
Unlock
, the lowest is
JPY374b 3.56%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 JPY387b 18.99%
2025
JPY408b 5.43%
Unlock
2026
JPY451b 10.41%
Unlock
2027
JPY549b 21.71%
Unlock
2028
JPY639b 16.51%
Unlock
2029
JPY723b 13.05%
Unlock

Net Margin

2024 33.09% 12.96%
2025
34.41% 3.99%
Unlock
2026
36.60% 6.36%
Unlock
2027
42.22% 15.36%
Unlock
2028
45.08% 6.77%
Unlock
2029
48.46% 7.50%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share JPY 235.39 248.16
18.99% 5.43%
P/E 26.81

7 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

JPY248.16
Unlock
. This is
5.43% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
JPY270.72 15.01%
Unlock
, the lowest is
JPY227.00 3.56%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 JPY235.39 18.99%
2025
JPY248.16 5.43%
Unlock
2026
JPY274.01 10.42%
Unlock
2027
JPY333.49 21.71%
Unlock
2028
JPY388.54 16.51%
Unlock
2029
JPY439.24 13.05%
Unlock

P/E ratio

Current 28.26 7.82%
2025
26.81 5.13%
Unlock
2026
24.28 9.44%
Unlock
2027
19.95 17.83%
Unlock
2028
17.12 14.19%
Unlock
2029
15.15 11.51%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today